USV Starts New Manufacturing Plant in Baddi

USV Starts New Manufacturing Plant in Baddi

By, Admin 15 March 2024

USV opens new manufacturing plant in Baddi to strengthen cardiology segment

Overview

USV, an Indian multinational healthcare company, announced the opening of a dedicated new manufacturing plant in Baddi, The new dedicated facility will improve access to high quality and affordable Ecosprin AV and further strengthen its leadership in the cardiology segment. With this new facility, the product will now be available in a more patient friendly pack. 

Increasing Risk

There are an increasing number of cases of cardiac events in our country even for younger individuals. Aspirin and atorvastatin play a vital role in heart health to protect patients from cardiac events. 

Plant Inauguration 

The plant was inaugurated by Debabrata Bhadury, director, USV in the presence of USV chairperson Leena Gandhi Tewari and managing director Prashant Tewari. 

Leaders on Inauguration

  • “This modern facility is of strategic importance to serve Indians to keep their heart healthy by offering a lifesaving quality brand at an affordable price”, said Leena Gandhi Tewari at the plant inauguration.
  • Prashant Tewari, managing director said “This new unit at Baddi will contribute further to our responsibility of saving lives through offering quality medicines.”

 
The New Facility

  • The plant uses high-tech machinery and advanced technology in manufacturing and automated process checks to assure product quality and efficacy. 
  • This meets the long term endeavour of contributing effectively to the well-being of patients with heart ailments by enhancing patient outcomes. 
  • The plant has many green initiatives like renewable energy usage, rainwater harvesting, and tree plantation already incorporated, right from inception.

Director’s Word on the Plant

M M Venkatachalam, director USV said “The facility is very impressive and upgraded in terms of technology used, automation, QC, testing and sustainability practice. In the recent past USV has made great strides in new facilities, technologies, efficiencies, and capacities.” 

About USV

Established in 1961, USV Private Limited is one of the leading Indian multinational healthcare companies with a presence in 65+ countries, with its products. In India, it is recognized for its leadership in the oral anti-diabetic and cardiology markets where it ranks #1 by prescriptions.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!